Brief: Pharmaxis Ltd Says FDA Clears Pharmaxis Cancer Drug To Progress To Phase 2 Study In Liver Cancer

Syntara

09/11/2021 01:19

Nov 9 (Reuters) - Pharmaxis Ltd  PXS.AX :
    * FDA CLEARS PHARMAXIS CANCER DRUG TO PROGRESS TO PHASE 2
STUDY IN
LIVER CANCER

Source text for Eikon:  ID:nASXbmVwdl 
Further company coverage:  PXS.AX 

 ((Reuters.Briefs@thomsonreuters.com;))